Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Associations have been reported of aromatase polymorphisms with Alzheimer's disease (AD). We studied nine polymorphisms in 207 cases of AD, 23 cases of mild cognitive impairment (MCI) and 233 controls, all from the OPTIMA cohort. We replicated two reported associations and found others. Our findings were consistent between AD and MCI. Further, our results were sex-specific, i.e. there were significant interactions between certain polymorphisms and gender, and the associations with AD were almost entirely in women. Aromatase catalyses the conversion of androgens to estrogens. It is expressed in the human brain. In the hippocampus, it is upregulated in postmenopausal women and is lowered in AD. These sex-specific results are therefore plausible. However, our results now need to be replicated in a larger dataset.

Original publication

DOI

10.1016/j.neulet.2009.10.089

Type

Journal article

Journal

Neurosci Lett

Publication Date

14/01/2010

Volume

468

Pages

202 - 206

Keywords

Aged, Aged, 80 and over, Alzheimer Disease, Aromatase, Cognition Disorders, Female, Genetic Association Studies, Genetic Predisposition to Disease, Humans, INDEL Mutation, Linkage Disequilibrium, Longitudinal Studies, Male, Microsatellite Repeats, Polymorphism, Single Nucleotide, Sex Factors